The expression of CD107a is considered a biomarker to evaluate the cytotoxic capacity [66], and it has been described to be reduced in the surface of cells isolated from individuals with COVID-19, in comparison with uninfected, healthy donors [15]. Here, LAMP1 is linked to COVID-19.